The Rhythm Biosciences Ltd (ASX: RHY) share price has opened higher on Tuesday after the successful completion of Study 6 for its ColoSTAT product. At the time of writing, the Rhythm share price is trading at $1.60, up 6.33%.
Let’s take a closer look at this announcement and what it means for the Rhythm share price.
Why the Rhythm share price opened higher on Tuesday
The Rhythm share price has surged. Climbing from a low of 3.5 cents 12-months ago to a high of $1.675 on 2 March. The company continues to hit significant milestones. In particular, for the commercialisation of its simple, affordable, and effective ColoSTAT blood test….
The post The Rhythm (ASX:RHY) share price surges on cancer testing milestone appeared first on Mackay Online News.
Warren Ruth is still early into his career as tech and digital marketing reporter but has already had his work published in many major publications including JoyStiq and Android Authority. In regards to academics, Warren earned a degree in business from CSUF. Warren has a passion for emerging technology and covers upcoming products and breakthroughs in science and tech.